Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-04-10FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a Supplemental Application for JANUMET XR (sitagliptin and metformin hydrochloride) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management [Phase 3]
A Phase 3 trial evaluated a tablet-based workflow with an integrated software algorithm for glycemic management in Type 2 diabetes; the stud…
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs [Phase 4]
Phase 4 trial evaluating different insulin administration strategies in combination with metformin to improve glycemic control in adults wit…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Exercise Training in Patients With Coronary Heart Disease and Type 2 Diabetes [NA]
This clinical trial update indicates that the exercise training study in patients with coronary artery disease and type 2 diabetes has compl…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial evaluating the efficacy of combining alogliptin with pioglitazone in Type 2 diabetes mellitus. Results were posted after study…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus. [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of combining alogliptin with pioglitazone in adults with Type 2 Diabetes Mellitus;…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study [Phase 4]
A Sanofi-sponsored Phase 4 trial comparing a basal-bolus insulin strategy using insulin glargine and insulin glulisine versus a premixed ins…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Nighttime Dosing of Antihypertensive Drugs in Type 2 Diabetes [NA]
This completed clinical trial evaluated whether nighttime dosing of antihypertensive medications improves blood pressure control in adults w…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Evaluating the Effects of a Diet and Exercise Program in People With Type 2 Diabetes or Prediabetes: (The SHAPE3 Study) [Phase 4]
This entry notes that the SHAPE3 Phase 4 clinical trial evaluating a diet and exercise program for adults with type 2 diabetes or prediabete…
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes [EARLY_Phase 1]
An early-phase (Phase 1) trial studied the effects of glucose-dependent insulinotropic peptide (GIP) during insulin-induced hypoglycemia in …
-
FDA approval · 2013-03-29FDA Approved: INVOKANA — Original Application (Janssen Pharmaceuticals, Inc.)
FDA approved INVOKANA (canagliflozin) through its original application, establishing this drug as a novel therapy for adults with type 2 dia…
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: A Study of the Effects of Exercise Intensity on Insulin Sensitivity in Overweight Youth [Phase 4]
A Phase 4 trial examining how exercise intensity affects insulin sensitivity in overweight youth with Type 2 diabetes mellitus and obesity; …
-
FDA approval · 2013-03-28FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
FDA approval · 2013-03-28FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly and Company. The action concerns the su…
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: Study Comparing Efficacy and Safety of Amaryl M and Metformin Uptitraion to Type 2 DM [Phase 4]
Phase 4 trial evaluating the efficacy and safety of up-titration of Amaryl M (glimepiride/metformin) with potential metformin uptitration fo…
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus [Phase 4]
Phase 4 clinical trial comparing Amaryl M 1/500 mg twice daily versus Amaryl 4 mg, both in combination with Lantus, for efficacy and safety …
-
FDA approval · 2013-03-27FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine), a pen formulation, filed by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 clinical trial evaluating the efficacy of combining alogliptin with pioglitazone (Actos) in adults with Type 2 diabetes mellitus; re…
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: Dance Dance Revolution (DDR) in Type 2 Diabetes [NA]
This document reports the completion of a clinical trial evaluating the Dance Dance Revolution exercise intervention for Type 2 Diabetes Mel…
-
EMA safety_alert · 2013-03-26European Medicines Agency investigates findings on pancreatic risks with GLP-1-based therapies for type-2 diabetes
EMA is investigating pancreatic risk findings associated with GLP-1–based therapies used for type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating the efficacy and safety of adding alogliptin to metformin in adults with Type 2 diabetes; results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone [Phase 3]
A Phase 3 trial comparing linagliptin to placebo in people with type 2 diabetes mellitus who have inadequate glycemic control on metformin p…
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients [Phase 2]
This clinical trial update reports the completed Phase 2 study evaluating the safety, tolerability, and efficacy of three dose levels of Mit…
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes [Phase 3]
Phase 3 clinical trial update reporting efficacy and safety data for alogliptin in adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus [Phase 3]
This document reports the long-term safety results from a Phase 3 trial of alogliptin in patients with type 2 diabetes mellitus.